Inherited epidermolysis bullosa and squamous cell carcinoma: A systematic review of 117 cases

Orphanet Journal of Rare Diseases

Volumn 11, Issue 1, 2016, Pages

  Montaudie H ^a   Chiaverini, C ^a   Sbidian, E ^b   Charlesworth, A ^a   Lacour, J P ^a  

^a UNIVERSITY HOSPITAL OF NICE   (France)

^b HENRI MONDOR HOSPITAL   (France)

Author keywords

Chemotherapy; Cutaneous squamous cell carcinoma; Inherited epidermolysis bullosa; Radiotherapy; Systematic review; Target therapy

Indexed keywords

AGE; ARTICLE; CANCER DIAGNOSIS; CANCER RISK; CANCER SUSCEPTIBILITY; DIAGNOSTIC PROCEDURE; DISEASE CLASSIFICATION; ELECTRON MICROSCOPY; EPIDERMOLYSIS BULLOSA HEREDITARIA; GENE MUTATION; HISTOPATHOLOGY; HUMAN; IMMUNOFLUORESCENCE; IMMUNOFLUORESCENCE ANTIGEN MAPPING; RETROSPECTIVE STUDY; SKIN BIOPSY; SQUAMOUS CELL CARCINOMA; SYSTEMATIC REVIEW; TUMOR VOLUME; EPIDERMOLYSIS BULLOSA; METABOLISM; PATHOLOGY; SKIN;

CARCINOMA, SQUAMOUS CELL; EPIDERMOLYSIS BULLOSA; HUMANS; SKIN;

EID: 84982261404     PISSN: None     EISSN: 17501172     Source Type: Journal    
DOI: 10.1186/s13023-016-0489-9     Document Type: Article

References (47)

1. Fine JD, Bruckner-Tuderman L, Eady RAJ, Bauer EA, Bauer JW, Has C, et al. Inherited epidermolysis bullosa: updated recommendations on diagnosis and classification. J Am Acad Dermatol. 2014;70:1103-26.
2. Fine JD, Mellerio JE. Extracutaneous manifestations and complications of inherited epidermolysis bullosa: part I. Epithelial associated tissues. J Am Acad Dermatol. 2009;61:367-84.
3. Fine JD, Johnson LB, Weiner M, Li KP, Suchindran C. Epidermolysis bullosa and the risk of life-threatening cancers: the National EB Registry experience, 1986-2006. J Am Acad Dermatol. 2009;60:203-11.
4. Mallipeddi R. Epidermolysis bullosa and cancer. Clin Exp Dermatol. 2002;27:616-23.
5. Yuen WY, Jonkman MF. Risk of squamous cell carcinoma in junctional epidermolysis bullosa, non-Herlitz type: report of 7 cases and a review of the literature. J Am Acad Dermatol. 2011;65:780-89.
6. Mellerio JE, Robertson SJ, Bernardis C, Diem A, Fine JD, George R, et al. Management of cutaneous squamous cell carcinoma in patients with epidermolysis bullosa: best clinical practice guidelines. Br J Dermatol. 2016;174:56-67.
7. Cuadrado-Corrales N, Sánchez-Jimeno C, García M, Ayuso C, De Lucas R, Vicario JL, et al. A recurrent nonsense mutation occurring as a de novo event in a patient with recessive dystrophic epidermolysis bullosa. Dermatology. 2011;223:219-21.
8. Weber F, Bauer JW, Sepp N, Högler W, Salmhofer W, Hintner H, et al. Squamous cell carcinoma in junctional and dystrophic epidermolysis bullosa. Acta Derm Venereol. 2001;81:189-92.
9. Rokunohe A, Nakano H, Aizu T, Kaneko T, Nakajima K, Ikenaga S, et al. Significance of sentinel node biopsy in the management of squamous cell carcinoma arising from recessive dystrophic epidermolysis bullosa. J Dermatol. 2008;35:336-40.
10. Mallipeddi R, Keane FM, McGrath JA, Mayou BJ, Eady RA. Increased risk of squamous cell carcinoma in junctional epidermolysis bullosa. J Eur Acad Dermatol Venereol. 2004;18:521-26.
11. Baek JO, Lee HY, Oh SW, Lee JS, Kim SC, Lee JR, et al. A novel homozygous keratin 14 mutation in a patient with autosomal recessive epidermolysis bullosa simplex and squamous cell carcinoma of the tongue. Br J Dermatol. 2010;162:880-82.
12. Schumann H, Roth W, Has C, Volz A, Erfurt-Berge C, Magin TM, et al. Verrucous carcinoma in epidermolysis bullosa simplex is possibly associated with a novel mutation in the keratin 5 gene. Br J Dermatol. 2012;167:929-36.
13. Mohr EB, Lohmeyer JA, Mikhaimer NC, Mailänder P, Schwarz T, Hauschild A, et al. Multiple squamous cell carcinomas in junctional epidermolysis bullosa: a surgical challenge. Dermatol Surg. 2008;34:1131-36.
14. Christiano AM, Crollick J, Pincus S, Uitto J. Squamous cell carcinoma in a family with dominant dystrophic epidermolysis bullosa: a molecular genetic study. Exp Dermatol. 1999;8:146-52.
15. Csikós M, Orosz Z, Bottlik G, Szöcs H, Szalai Z, Rozgonyi Z, et al. Dystrophic epidermolysis bullosa complicated by cutaneous squamous cell carcinoma and pulmonary and renal amyloidosis. Clin Exp Dermatol. 2003;28:163-66.
16. Huang L, Wong Y-P, Burd A. A novel homozygous splice site mutation in COL7A1 in a Chinese patient with severe recessive dystrophic epidermolysis bullosa and squamous cell carcinoma. Int J Dermatol. 2011;50:52-6.
17. Kawasaki H, Sawamura D, Iwao F, Kikuchi T, Nakamura H, Okubo S, et al. Squamous cell carcinoma developing in a 12-year-old boy with nonHallopeau-Siemens recessive dystrophic epidermolysis bullosa. Br J Dermatol. 2003;148:1047-50.
18. Tomita Y, Sato-Matsumura KC, Sawamura D, Matsumura T, Shimizu H. Simultaneous occurrence of three squamous cell carcinomas in a recessive dystrophic epidermolysis bullosa patient. Acta Derm Venereol. 2003;83:225-26.
19. Has C, Burger B, Volz A, Kohlhase J, Bruckner-Tuderman L, Itin P. Mild clinical phenotype of Kindler syndrome associated with late diagnosis and skin cancer. Dermatology. 2010;221:309-12.
20. Arita K, Wessagowit V, Inamadar AC, Palit A, Fassihi H, Lai-Cheong JE, et al. Unusual molecular findings in Kindler syndrome. Br J Dermatol. 2007;157:1252-56.
21. Arnold AW, Bruckner-Tuderman L, Zuger C, Itin PH. Cetuximab therapy of metastasizing cutaneous squamous cell carcinoma in a patient with severe recessive dystrophic epidermolysis bullosa. Dermatology. 2009;219:80-3.
22. Tsukada A, Fujimura T, Furudate S, Kambayashi Y, Numata Y, Haga T, Hashimoto A, et al. Cutaneous squamous cell carcinoma developing from recessive dystrophic epidermolysis bullosa: a case report and an immunohistochemical study. Case Rep Dermatol. 2012;4:197-01.
23. Larocca CA, Cordova AC, Price LA, Milner SM. Squamous cell carcinoma as a complication of epidermolysis bullosa. Am Surg. 2012;78:418-19.
24. Cardin-Langlois E, Hanna D, St-Amant M, Croteau F. Invasive squamous cell carcinoma of the hand in a patient with Kindler syndrome: Case report and literature review. Can J Plast Surg. 2010;18:41-3.
25. Perez-Naranjo L, Herrera-Saval A, Garcia-Bravo B, Perez-Bernal AM, Camacho F. Sentinel lymph node biopsy in recessive dystrophic epidermolysis bullosa and squamous cell carcinoma. Arch Dermatol. 2005;141:110-11.
26. Yamada M, Hatta N, Sogo K, Komura K, Hamaguchi Y, Takehara K. Management of squamous cell carcinoma in a patient with recessive-type epidermolysis bullosa dystrophica. Dermatol Surg. 2004;30:1424-29.
27. Schwartz RA, Birnkrant AP, Rubenstein DJ, Kim U, Burgess GH, Stoll HL, et al. Squamous cell carcinoma in dominant type epidermolysis bullosa dystrophica. Cancer. 1981;47:615-20.
28. Lentz SR, Raish RJ, Orlowski EP, Marion JM. Squamous cell carcinoma in epidermolysis bullosa. Treatment with systemic chemotherapy. Cancer. 1990;66:1276-78.
29. Kim M, Li M, Intong LRA, Tran K, Melbourne W, Marucci D, et al. Use of cetuximab as an adjuvant agent to radiotherapy and surgery in recessive dystrophic epidermolysis bullosa with squamous cell carcinoma. Br J Dermatol. 2013;169:208-10.
30. Didolkar MS, Gerner RE, Moore GE. Epidermolysis bullosa dystrophica and epithelioma of the skin. Review of published cases and report of an additional patient. Cancer. 1974;33:198-02.
31. Reed WB, College J, Francis MJ, Zachariae H, Mohs F, Sher MA, et al. Epidermolysis bullosa dystrophica with epidermal neoplasms. Arch Dermatol. 1974;110:894-02.
32. Keefe M, Wakeel RA, Dick DC. Death from metastatic, cutaneous, squamous cell carcinoma in autosomal recessive dystrophic epidermolysis bullosa despite permanent inpatient care. Dermatologica. 1988;177:180-84.
33. McGrath JA, Schofield OM, Mayou BJ, McKee PH, Eady RA. Metastatic squamous cell carcinoma resembling angiosarcoma complicating dystrophic epidermolysis bullosa. Dermatologica. 1991;182:235-38.
34. Schreiber MH, Cavallo FM, Dominguez VE, Ernst RD, Freedman CK, Glowczwski AC, et al. Image interpretation session: 1992. Esophageal strictures and squamous cell carcinoma of the maxillary sinus and palate in recessive epidermolysis bullosa dystrophica. Radiographics. 1993;13:169-71.
35. Bastin KT, Steeves RA, Richards MJ. Radiation therapy for squamous cell carcinoma in dystrophic epidermolysis bullosa: case reports and literature review. Am J Clin Oncol. 1997;20:55-8.
36. Lotem M, Raben M, Zeltser R, Landau M, Sela M, Wygoda M, et al. Kindler syndrome complicated by squamous cell carcinoma of the hard palate: successful treatment with high-dose radiation therapy and granulocyte-macrophage colony-stimulating factor. Br J Dermatol. 2001;144:1284-86.
37. Mseddi M, Turki H, Marrekchi S, Abdelmaksoud W, Masmoudi A, Bouassida S, et al. Squamous cell carcinoma complicating an hereditary epidermolysis bullosa. Cancer Radiother. 2004;8:266-69.
38. Souza CS, Felício LBA, Bentley MV, Tedesco AC, Ferreira J, Kurachi C, et al. Topical photodynamic therapy for Bowen's disease of the digit in epidermolysis bullosa. Br J Dermatol. 2005;153:672-74.
39. Emanuel PO, Rudikoff D, Phelps RG. Aggressive squamous cell carcinoma in Kindler syndrome. Skin Med. 2006;5:305-07.
40. Mizutani H, Masuda K, Nakamura N, Takenaka H, Tsuruta D, Katoh N. Cutaneous and laryngeal squamous cell carcinoma in mixed epidermolysis bullosa, kindler syndrome. Case Rep Dermatol. 2012;4:133-38.
41. Onsun N, Su O, Pirmit S, Korkmaz S, Korkut YA, Akaydin M, et al. A rare complication of hereditary epidermolysis bullosa: esophageal carcinoma in recessive dystrophic epidermolysis bullosa inversa. Eur J Dermatol. 2012;22:409-10.
42. Jambusaria-Pahlajani A, Kanetsky PA, Karia PS, Hwang W-T, Gelfand JM, Whalen FM, et al. Evaluation of AJCC tumor staging for cutaneous squamous cell carcinoma and a proposed alternative tumor staging system. JAMA Dermatol. 2013;149:402-10.
43. Karia PS, Jambusaria-Pahlajani A, Harrington DP, Murphy GF, Qureshi AA, Schmults CD. Evaluation of American Joint Committee on Cancer, International Union against Cancer, and Brigham and Women's Hospital tumor staging for cutaneous squamous cell carcinoma. J Clin Oncol. 2014;32:327-34.
44. Wagner JD, Evdokimow DZ, Weisberger E, Moore D, Chuang T-Y, Wenck S, et al. Sentinel node biopsy for high-risk nonmelanoma cutaneous malignancy. Arch Dermatol. 2004;140:75-9.
45. Khansur T, Kennedy A. Cisplatin and 5-fluorouracil for advanced locoregional and metastatic squamous cell carcinoma of the skin. Cancer. 1991;67:2030-32.
46. Alter M, Satzger I, Mattern A, Kapp A, Gutzmer R. Treatment of advanced cutaneous squamous cell carcinomas with epidermal growth factor receptor inhibitors. Dermatology. 2013;227:289-94.
47. Gray KA, Yates B, Seal RL, Wright MW, Bruford EA. genenames.org: the HGNC resources in 2015. Nucleic Acids Res. 2015. http://www.genenames. org. Accessed 11 Mar 2016